QCIG
AXDX

Quad-Cities Investment Group’s Accelerate Diagnostics AXDX Stock Holding History

Quad-Cities Investment Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40
Closed -$7K – 198
2019
Q3 		$7K Hold
40
– – 0.01% 652
2019
Q2 		$9K Hold
40
– – 0.01% 620
2019
Q1 		$8K Hold
40
– – 0.01% 614
2018
Q4 		$5K Hold
40
– – 0.01% 669
2018
Q3 		$9K Hold
40
– – 0.01% 629
2018
Q2 		$9K Buy
+40
New +$8.95K 0.01% 637

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Quad-Cities Investment Group's AXDX Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Accelerate Diagnostics (AXDX) in Q4 2019, closing a stake of 40 shares — an estimated $7K sold.

Quad-Cities Investment Group first reported a position in AXDX in Q2 2018 and held it in 6 quarters. The position peaked at $9K in Q2 2019. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2019.

  • Quad-Cities Investment Group reported no remaining Accelerate Diagnostics position as of Q4 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 40 Accelerate Diagnostics shares in Q4 2019, an estimated $7K.
  • Quad-Cities Investment Group first reported a position in Accelerate Diagnostics in Q2 2018 and held it in 6 quarters.
  • Quad-Cities Investment Group's Accelerate Diagnostics position peaked at $9K in Q2 2019.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.